HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loureirin B protects against cerebral ischemia/reperfusion injury through modulating M1/M2 microglial polarization via STAT6 / NF-kappaB signaling pathway.

Abstract
The latest research indicates that modulating microglial polarization from M1 to M2 phenotype may be a coping therapy for ischemic stroke. The present study thereby evaluated the effects of loureirin B (LB), a monomer compound extracted from Sanguis Draconis flavones (SDF), on cerebral ischemic injury and the potential mechanisms. The middle cerebral artery occlusion (MCAO) model was established in male Sprague-Dawley rats to induce cerebral ischemia/reperfusion (I/R) injury in vivo, and BV2 cells were exposed to oxygen-glucose deprivation and reintroduction (OGD/R) to mimic cerebral I/R injury in vitro. The results showed that LB significantly reduced infarct volume, neurological deficits and neurobehavioral deficits, apparently improved histopathological changes and neuronal loss in cortex and hippocampus of MCAO/R rats, markedly decreased the proportion of M1 microglia cells and the level of pro-inflammatory cytokines, and increased the proportion of M2 microglia and the level of anti-inflammatory cytokines both in vivo and in vitro. In addition, LB evidently improved the p-STAT6 expression and reduced the NF-κB (p-p65) expression after cerebral I/R injury in vivo and in vitro. IL-4 (a STAT6 agonist) exhibited a similar impact to that of LB, while AS1517499 (a STAT6 inhibitor) significantly reversed the effect of LB on BV-2 cells after OGD/R. These findings point to the protection of LB against cerebral I/R injury by modulating M1/M2 polarization of microglia via the STAT6/NF-κB signaling pathway, hence LB may be a viable treatment option for ischemic stroke.
AuthorsRui Li, Huiyu Jia, Min Si, Xinwei Li, Zheng Ma, Yu Zhu, Wuyi Sun, Fengqin Zhu, Shengyong Luo
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 953 Pg. 175860 (Aug 15 2023) ISSN: 1879-0712 [Electronic] Netherlands
PMID37331681 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2023 Elsevier B.V. All rights reserved.
Chemical References
  • NF-kappa B
  • loureirin B
  • Cytokines
Topics
  • Rats
  • Male
  • Animals
  • NF-kappa B (metabolism)
  • Microglia
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Infarction, Middle Cerebral Artery (complications, drug therapy, metabolism)
  • Brain Injuries (metabolism)
  • Reperfusion Injury (drug therapy, prevention & control, metabolism)
  • Ischemic Stroke (metabolism)
  • Cytokines (metabolism)
  • Brain Ischemia (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: